We are evaluating our technology with some of the world’s leading pharmaceutical and biotechnology companies who are using our polymer platform to develop novel therapeutics to address significant unmet medical needs. We welcome the opportunity to discuss this with you.

Please contact Business Development at

POZ™ Platform

How We and Our Partners Employ the Technology

Half-life extension of proteins, including antibodies and antibody fragments

Overcoming immunogenicity of foreign polypeptides

Programmed release of small molecules

Targeting of POZ-polymers to specific receptors and target tissues